| Sign In to gain access to subscriptions and/or personal tools. |
A Statistical Perspective on the Design of Drug-Court StudiesMRC Biostatistics Unit, Cambridge, United Kingdom, Elizabeth.merrall{at}mrc-bsu.cam.ac.uk
MRC Biostatistics Unit, Cambridge, United kingdom Strathclyde University, Glasgow, United Kingdom Recent meta-analyses of drug-court studies recognized the poor methodological quality of the evaluations, with only a few being randomized. This article critiques the design of the randomized studies from a statistical perspective. Learning points are identified for future drug-court studies and are applicable to evaluations both of other specialist courts and of court-based interventions more generally. The specific issues covered are randomization, describing the intervention, and baseline characteristics; study outcomes, and sample size calculations; in-program and postprogram behavior, analysis plan, and presentation of results.
Key Words: drug-courts study design statistical randomization
This version was published on June
1, 2009 Evaluation Review, Vol. 33, No. 3,
257-280 (2009) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||